Cardiothoracic & vascular anesthesia

Hemodynamic Response to Intubation With 4 Different Laryngoscopes in Coronary Artery Bypass Graft Surgery: A Randomized Trial

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

Videolaryngoscopes conferred no hemodynamic advantage over direct laryngoscopy during intubation in deeply anesthetized patients undergoing CABG.

Study context

Population
Adults scheduled for elective coronary artery bypass graft (CABG) with no anticipated difficult airway, under standardized deep anesthesia
Participants
112 adults
Comparison
Macintosh laryngoscope vs C-MAC, EzVision or McGrath videolaryngoscope
Primary endpoint
Hemodynamic stress response: ΔMAP and ΔHR between after induction before NMB (T2) and 1 minute after tracheal intubation (T4)
Follow-up
1 minute after tracheal intubation
Methodological detailsprospective, single-centre, University-affiliated tertiary care hospital
  • Prospective
  • Single-centre
  • University-affiliated tertiary care hospital

Primary result

As reported in the abstract

ΔMAP · T2 to T4

Macintosh

20.8

mean · SD 19.4 · mmHg

C-MAC

26.3

mean · SD 13.6 · mmHg

EzVision

21.8

mean · SD 12.4 · mmHg

McGrath

28.4

mean · SD 11.9 · mmHg

P = 0.168

Further findings

Hemodynamic stress response (MAP increase ≥10 mmHg and/or HR increase ≥10 bpm) · across 4 groups

P = 0.653

Intubation time · across 4 groups

P < 0.001

Mean, bpm

OutcomeMacintoshC-MACEzVisionMcGrathP value
ΔHR (co-primary) · T2 to T4Across 4 groups7.4 (SD 8.2)6.1 (SD 10.6)8.6 (SD 16.4)7.5 (SD 7.7)P = 0.844

Intubation success

Similar across groups

Safety

Complication profiles similar across groups

Original publication

Hemodynamic Response to Intubation With 4 Different Laryngoscopes in Coronary Artery Bypass Graft Surgery: A Randomized Trial. J Cardiothorac Vasc Anesth. Published 5 April 2026. doi:10.1053/j.jvca.2026.03.050

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.